The discovery, development and utility of selective estrogen receptor modulators (SERMs) are presented
in this study. As per literature review SERMs used in the treatment of estrogen hormone responsive
diseases like osteoporosis, Alzheimer, angiogenesis, hyperlipidemia, coronary heart disease,
atherosclerosis, endometriosis, breast cancer, post-menopausal depression, dysfunctional uterine
bleeding, gynacomastia, Albright syndrome, ovarian cancer, dyspareunia, cyclical mastalgia,
hypogondism and induced ovulation in sub-fertile woman, etc. Basically world wide a large no.
compounds available those function as SERMs successfully or under different phase clinical trials or
discontinued because of unwanted side effects during clinical trials. This work describes the specific
reference compounds which have created a substitute of estrogen for treating hormone dependent
issues.